Sandy Spring Bank Bio N Tech Se Transaction History
Sandy Spring Bank
- $2.42 Billion
- Q4 2024
A detailed history of Sandy Spring Bank transactions in Bio N Tech Se stock. As of the latest transaction made, Sandy Spring Bank holds 2 shares of BNTX stock, worth $241. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2
Previous 2
-0.0%
Holding current value
$241
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BNTX
# of Institutions
361Shares Held
39.6MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$991 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$531 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$518 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$228 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$218 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $29.3B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...